Medilink-Global UK (LSE:MEDI) EBITDA Margin %: 48.46% (As of Jun. 2016)


What is Medilink-Global UK EBITDA Margin %?

Medilink-Global UK LSE:MEDI +100.00% EBITDA Margin % is 48.46% as of Jun. 2016. The stock has 4 warning signs investors should review.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Medilink-Global UK's EBITDA for the six months ended in Jun. 2016 was £0.46 Mil. Medilink-Global UK's Revenue for the six months ended in Jun. 2016 was £0.94 Mil. Therefore, Medilink-Global UK's EBITDA margin for the quarter that ended in Jun. 2016 was 48.46%.

Medilink-Global UK  (LSE:MEDI) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Medilink-Global UK EBITDA Margin % Related Terms

Medilink-Global UK EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Medilink-Global UK's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medilink-Global UK EBITDA Margin % Chart

Medilink-Global UK Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
EBITDA Margin %
Get a 7-Day Free Trial -164.66 -23.70 -23.10 -128.97 28.51

Medilink-Global UK Semi-Annual Data
Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.76 -242.40 -9.80 60.77 48.46

Medilink-Global UK EBITDA Margin % Competitor Comparison

For the Health Information Services subindustry, Medilink-Global UK's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medilink-Global UK EBITDA Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medilink-Global UK's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Medilink-Global UK's EBITDA Margin % falls into.


Medilink-Global UK EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Medilink-Global UK's EBITDA Margin % for the fiscal year that ended in Dec. 2015 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2015 )/Revenue (A: Dec. 2015 )
=0.439/1.54
=28.51 %

Medilink-Global UK's EBITDA Margin % for the quarter that ended in Jun. 2016 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2016 )/Revenue (Q: Jun. 2016 )
=0.456/0.941
=48.46 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 48.46% mean?
Medilink-Global UK (LSE:MEDI) has a EBITDA Margin % of 48.46% as of Jun. 2016. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Medilink-Global UK and its competitors.
Is Medilink-Global UK's EBITDA Margin % too high?
Medilink-Global UK's current EBITDA Margin % is 48.46%. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. Medilink-Global UK's value of 48.46% is 373.5% above this industry median.
How does Medilink-Global UK's EBITDA Margin % compare to competitors?
Medilink-Global UK's EBITDA Margin % of 48.46% can be compared against companies in the Healthcare Providers & Services industry. The industry median EBITDA Margin % is 10.24. Medilink-Global UK's value of 48.46% is 373.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medilink-Global UK's current EBITDA Margin % of 48.46% is 373.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Medilink-Global UK and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medilink-Global UK's current EBITDA Margin % is 48.46%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medilink-Global UK stock overvalued right now?
Medilink-Global UK (LSE:MEDI) has a current EBITDA Margin % of 48.46%. The current EBITDA Margin % is 48.46% and 373.5% above the Healthcare Providers & Services industry median of 10.24. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Medilink-Global UK (LSE:MEDI), the current EBITDA Margin % is 48.46% as of Jun. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medilink-Global UK Business Description

Medilink-Global UK Ltd was incorporated in Jersey. The Company provides third party administrator services via Electronic Healthcard Network that facilitate the administration of medical claims and healthcare data management for insurance companies and corporate clients. The Company's operating segments are Third party administrator segment is derived from aggregating Malaysia and Singapore entity, while Software licensing segment represent a single entity from Malaysia.